Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer
PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment
23
Participants
Timeline
Start Date
April 30, 2000
Study Completion Date
November 30, 2004
Conditions
Colorectal Cancer
Interventions
DRUG
irinotecan
DRUG
leucovorin
DRUG
fluorouracil
Trial Locations (1)
060-8638
Hokkaido University Hospital, Sapporo
All Listed Sponsors
lead
Hokkaido Gastrointestinal Cancer Study Group
OTHER
NCT00209625 - Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter